Utility of Novel BRAF Test for Melanoma
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Melanoma
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
There will be no extra clinic visits for this study. These research blood samples will be drawn at the same time as your regularly scheduled blood draws that are part of standard care for melanoma. About 2 to 4 teaspoons of blood will be drawn for each research sample. Depending on which group you a...
There will be no extra clinic visits for this study. These research blood samples will be drawn at the same time as your regularly scheduled blood draws that are part of standard care for melanoma. About 2 to 4 teaspoons of blood will be drawn for each research sample. Depending on which group you are in, you will have either a one time blood draw or ongoing blood work for 1-2 years.
Tracking Information
- NCT #
- NCT01840527
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ryan Sullivan, MD Massachusetts General Hospital